[{"Assets_0_Q1_USD":284780000.0,"CommonStockSharesOutstanding_0_Q1_shares":36742847.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-11144000.0,"NetIncomeLoss_1_Q1_USD":-35037000.0,"StockholdersEquity_0_Q1_USD":236641000.0,"Ticker":"RVNC","CIK":"1479290","name":"REVANCE THERAPEUTICS, INC.","OfficialName":"Revance Therapeutics Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1265045755.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180509"}]